Bank of New York Mellon
MXCT icon

Bank of New York Mellon’s MaxCyte MXCT Stock Holding History

Bank of New York Mellon’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.8K Sell
80,340
-323,597
-80% -$322K ﹤0.01% 4198
2026
Q1 		$284K Buy
403,937
+62,477
+18% +$58.3K ﹤0.01% 3883
2025
Q4 		$529K Sell
341,460
-22,468
-6% -$35.9K ﹤0.01% 3582
2025
Q3 		$575K Buy
363,928
+18,113
+5% +$31.5K ﹤0.01% 3513
2025
Q2 		$754K Buy
345,815
+344
+0.1% +$833 ﹤0.01% 3281
2025
Q1 		$943K Buy
345,471
+9,337
+3% +$36.8K ﹤0.01% 3103
2024
Q4 		$1.4M Sell
336,134
-9,472
-3% -$35.8K ﹤0.01% 2938
2024
Q3 		$1.34M Sell
345,606
-77,603
-18% -$327K ﹤0.01% 2972
2024
Q2 		$1.66M Buy
423,209
+83,025
+24% +$357K ﹤0.01% 2900
2024
Q1 		$1.43M Sell
340,184
-41,649
-11% -$196K ﹤0.01% 2952
2023
Q4 		$1.79M Buy
381,833
+42,459
+13% +$165K ﹤0.01% 2892
2023
Q3 		$1.06M Sell
339,374
-4,453
-1% -$17.9K ﹤0.01% 3115
2023
Q2 		$1.58M Buy
343,827
+9,940
+3% +$45.7K ﹤0.01% 2960
2023
Q1 		$161M Sell
333,887
-4,395
-1% -$21.6K 0.04% 440
2022
Q4 		$1.78M Buy
338,282
+4,509
+1% +$27.6K ﹤0.01% 2916
2022
Q3 		$2.17M Buy
333,773
+63,691
+24% +$355K ﹤0.01% 2791
2022
Q2 		$1.28M Sell
270,082
-31,091
-10% -$153K ﹤0.01% 3087
2022
Q1 		$2.1M Sell
301,173
-33,607
-10% -$229K ﹤0.01% 2906
2021
Q4 		$3.41M Buy
334,780
+261,604
+357% +$2.81M ﹤0.01% 2668
2021
Q3 		$893K Buy
+73,176
New +$1.1M ﹤0.01% 3452

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Bank of New York Mellon's MXCT Position: Q2 2026 in Review

Bank of New York Mellon reduced its MaxCyte (MXCT) stake by 80% in Q2 2026, selling an estimated $322K and leaving 80,340 shares worth $98.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4198.

Bank of New York Mellon first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $161M in Q1 2023. 60 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Bank of New York Mellon held 80,340 shares of MaxCyte worth $98.8K as of Q2 2026.
  • Bank of New York Mellon sold 323,597 MaxCyte shares in Q2 2026, an estimated $322K.
  • MaxCyte made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4198 holding.
  • Bank of New York Mellon first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
  • Bank of New York Mellon's MaxCyte position peaked at $161M in Q1 2023.
  • 60 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.